Literature DB >> 33757622

Role of Noncoding RNAs in Acetaminophen-Induced Liver Injury.

Vivek Chowdhary1, Pipasha Biswas2, Kalpana Ghoshal1.   

Abstract

Genomic and transcriptomic analyses have well established that the major fraction of the mammalian genome is transcribed into different classes of RNAs ranging in size from a few nucleotides to hundreds of thousands of nucleotides, which do not encode any protein. Some of these noncoding RNAs (ncRNAs) are directly or indirectly linked to the regulation of expression or functions of 25,000 proteins coded by <2% of the human genome. Among these regulatory RNAs, microRNAs are small (2125 nucleotides) RNAs that are processed from precursor RNAs that have stemloop structure, whereas noncoding RNAs >200 nucleotides are termed long noncoding RNAs (lncRNAs). Circular RNAs (circRNAs) are newly identified lncRNA members that are generated by back-splicing of primary transcripts. The functions of ncRNAs in modulating liver toxicity of xenobiotics are emerging only recently. Acetaminophen (N-acetyl-para-aminophenol, paracetamol or APAP) is a safe analgesic and antipyretic drug at the therapeutic dose. However, it can cause severe liver toxicity that may lead to liver failure if overdosed or combined with alcohol, herbs, or other xenobiotics. This review discusses the role of ncRNAs in acetaminophen metabolism, toxicity, and liver regeneration after APAP-induced liver injury (AILI).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33757622      PMCID: PMC8201654          DOI: 10.3727/105221621X16165282414118

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  59 in total

Review 1.  miR-122, a paradigm for the role of microRNAs in the liver.

Authors:  Muriel Girard; Emmanuel Jacquemin; Arnold Munnich; Stanislas Lyonnet; Alexandra Henrion-Caude
Journal:  J Hepatol       Date:  2008-02-12       Impact factor: 25.083

2.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

3.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Authors:  Shu-Hao Hsu; Bo Wang; Janaiah Kota; Jianhua Yu; Stefan Costinean; Huban Kutay; Lianbo Yu; Shoumei Bai; Krista La Perle; Raghu R Chivukula; Hsiaoyin Mao; Min Wei; K Reed Clark; Jerry R Mendell; Michael A Caligiuri; Samson T Jacob; Joshua T Mendell; Kalpana Ghoshal
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

Review 4.  miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir.

Authors:  Sharda Thakral; Kalpana Ghoshal
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

5.  Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines.

Authors:  C M Hogaboam; C L Bone-Larson; M L Steinhauser; N W Lukacs; L M Colletti; K J Simpson; R M Strieter; S L Kunkel
Journal:  FASEB J       Date:  1999-09       Impact factor: 5.191

6.  Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen.

Authors:  D J Jollow; S S Thorgeirsson; W Z Potter; M Hashimoto; J R Mitchell
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

7.  MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity.

Authors:  Pritmohinder Gill; Sudeepa Bhattacharyya; Sandra McCullough; Lynda Letzig; Prasun J Mishra; Chunqiao Luo; Harsh Dweep; Laura James
Journal:  Sci Rep       Date:  2017-09-26       Impact factor: 4.379

8.  CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I.

Authors:  Nan Li; Shixue Gou; Jiaowei Wang; Quanjun Zhang; Xingyun Huang; Jingke Xie; Li Li; Qin Jin; Zhen Ouyang; Fangbing Chen; Weikai Ge; Hui Shi; Yanhui Liang; Zhenpeng Zhuang; Xiaozhu Zhao; Meng Lian; Yinghua Ye; Longquan Quan; Han Wu; Liangxue Lai; Kepin Wang
Journal:  Mol Ther       Date:  2020-11-20       Impact factor: 11.454

9.  Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.

Authors:  David S Hong; Yoon-Koo Kang; Mitesh Borad; Jasgit Sachdev; Samuel Ejadi; Ho Yeong Lim; Andrew J Brenner; Keunchil Park; Jae-Lyun Lee; Tae-You Kim; Sangjoon Shin; Carlos R Becerra; Gerald Falchook; Jay Stoudemire; Desiree Martin; Kevin Kelnar; Heidi Peltier; Vinicius Bonato; Andreas G Bader; Susan Smith; Sinil Kim; Vincent O'Neill; Muhammad S Beg
Journal:  Br J Cancer       Date:  2020-04-02       Impact factor: 7.640

10.  The MicroRNA-based Liquid Biopsy Improves Early Assessment of Lethal Acetaminophen Poisoning: A Case Report.

Authors:  Julian Krauskopf; Mark M Gosink; Shelli Schomaker; Florian Caiment; Roscoe Warner; Kent Johnson; Jos Kleinjans; Jiri Aubrecht
Journal:  Am J Case Rep       Date:  2020-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.